DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Kudo M.
Scientific rationale for combined immunotherapy with PD-1/PD-L1 antibodies and VEGF inhibitors in advanced hepatocellular carcinoma.
Cancers (Basel) 2020;
12 (05) 1089
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.